Chromosome 1, monosomy 1p31 p22
Chromosome 1, monosomy 1p31 p22 is a rare chromosomal abnormality involving a deletion on the short arm of chromosome 1. This condition is characterized by the loss of genetic material between the 1p31 and 1p22 regions on chromosome 1. The clinical manifestations and severity of symptoms can vary widely among affected individuals, depending on the exact size and location of the deletion and the genes involved.
Clinical Features[edit | edit source]
Individuals with Chromosome 1, monosomy 1p31 p22, may present with a range of clinical features, which can include developmental delay, intellectual disability, growth retardation, and various physical anomalies. Common physical features may include distinctive facial features, such as a broad forehead, deep-set eyes, and a small jaw. Other possible features include heart defects, abnormalities of the skeletal system, and issues with the nervous system.
Genetics[edit | edit source]
The condition is caused by a deletion of genetic material on the short arm of chromosome 1, specifically between the 1p31 and 1p22 regions. This deletion can occur sporadically, with no previous family history of the condition. The exact mechanism leading to the deletion is not fully understood, but it may involve errors during the replication of DNA or during meiosis.
Diagnosis[edit | edit source]
Diagnosis of Chromosome 1, monosomy 1p31 p22 typically involves genetic testing and analysis, such as karyotyping or more advanced techniques like fluorescence in situ hybridization (FISH) or array comparative genomic hybridization (aCGH). These tests can identify the specific chromosomal deletion and help in understanding the potential impact on the individual.
Management[edit | edit source]
Management of Chromosome 1, monosomy 1p31 p22 is symptomatic and supportive. It may involve a multidisciplinary team of healthcare professionals, including pediatricians, geneticists, neurologists, cardiologists, and therapists (physical, occupational, and speech). Early intervention and supportive therapies can help in managing developmental delays and improving the quality of life for affected individuals.
Prognosis[edit | edit source]
The prognosis for individuals with Chromosome 1, monosomy 1p31 p22 varies widely and is dependent on the severity of the symptoms and the presence of life-threatening complications. With appropriate management and supportive care, many individuals can lead a relatively normal life.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD